Shares of Accolade (NASDAQ: ACCD) were up as much as 25% for the week early Friday, according to data provided by S&P Global Market Intelligence. The independent health benefits navigator announced third-quarter earnings on Monday. Accolade reported revenue of $90.9 million, up 9% year over year, and a net income loss of $39.9 million, compared to positive net income of $22.5 in the same period a year ago.
Accolade (ACCD) delivered earnings and revenue surprises of 8.20% and 4.43%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
Fiscal third quarter 2023 revenue of $90.9 million, a 9% increase compared to fiscal third quarter 2022 revenue of $83.5 million SEATTLE, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2022. “Accolade enters the new year having just concluded one of the strongest selling performances in our company’s history. Notably, the strength in our business is driven by the increasing diversity in our platfor